Fundraising FoxBayMed Venture Partners — 2018 Investments
2 investments dated 2018 · listed companies and verified rows first · show all
Combinati developed the QuantStudio Absolute Q Digital PCR System, which uses microfluidic array plate (MAP) technology for detection and quantification of nucleic acids, rare mutations, and genome editing events.
BiotechDeep TechHardwarePalo Alto, US
Michael Mokelke(Director)Ju-Sung (Paul) Hung(Executive Officer, Director)Charles Collins(Director)
Co-investorsBand of AngelsEndurance28IT-Farm Corporation
VALFIX develops a transcatheter mitral valve repair system with a robotic interface, designed to convert open-heart valve surgery into a minimally invasive transcatheter procedure.
BiotechHealthtechMedical DevicesRoboticsTel Aviv-Yafo
Philip Lavin(Director)Elad Yaacoby(Director)Eli Bar(Executive Officer, Director)
BoardGary Gershony(Director)in
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.